A carregar...
Long‐term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11‐year, open‐label, follow‐up trial
OBJECTIVE: To evaluate long‐term safety/tolerability of brivaracetam at individualized doses ≤200 mg/d (primary) and maintenance of efficacy over time (secondary) in adults with focal seizures or primary generalized seizures (PGS) enrolled in phase 3, open‐label, long‐term follow‐up trial N01199 (NC...
Na minha lista:
| Publicado no: | Epilepsia |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7384045/ https://ncbi.nlm.nih.gov/pubmed/32221987 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/epi.16484 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|